Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT06232486

Relationship Between Serum Vitamin D Levels and Postherpetic Neuralgia.

Association Between Serum Vitamin D and Postherpetic Neuralgia, A Prospective Observation Study.

Status
Active Not Recruiting
Phase
Study type
Observational
Enrollment
144 (estimated)
Sponsor
Feng Gao · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

1. The correlations of serum vitamin D level, serum calcium level and osteoporosis degree with disease severity, treatment response, incidence of Post-Herpes zoster(PHN) and disease prognosis in Herpes zoster(HZ) patients were studied. 2. To investigate the role of inflammation-related factors and immune-related factors in the occurrence and development of HZ mediated by low vitamin D level.

Detailed description

Herpes zoster is a neuropathic disease which induce by the varicella-herpes virus reactivation.and postherpetic neuralgia (PHN) is the most common complication. Currently,the mechanism of herpes zoster still unclearly even though there had much study about it .Vitamin D is an essential vitamin for human body, which has the function of maintaining calcium and phosphorus homeostasis and immune regulation. Vitamin D is a natural antiviral substance, and vitamin D deficiency can affect the body's antiviral ability, thereby promoting varicella-zoster virus(VZV) reactivation, and may promote the development of PHN through continuous neuroinflammation. Therefore, vitamin D level may be related to the occurrence and progression of HZ. this study intends to use an observational cohort study design to investigate the correlation of serum vitamin D level and osteoporosis degree with the severity of the herpes zoster disease, Although we plan to further explore the role of inflammatory state in this process.

Conditions

Timeline

Start date
2023-12-01
Primary completion
2025-12-31
Completion
2026-12-31
First posted
2024-01-30
Last updated
2024-01-30

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06232486. Inclusion in this directory is not an endorsement.